Trial intelligence / Profile preview

Qu Feng Zhi Tong Capsule for knee osteoarthritis

ChiCTR1800018214Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Harbin Medical University
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of Qu Feng Zhi Tong in knee osteoarthritis (OA) (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: knee pain index (VAS score). Started Oct 2017; status: recruiting.

02

Drugs

Qu Feng Zhi Tong
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR1800018214.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800018214.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call